Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
09/2000
09/14/2000WO2000053761A2 Human cytokine as ligand of the zalpha receptor and uses thereof
09/14/2000WO2000053760A2 Method of preventing the death of retinal neurons and treating ocular diseases
09/14/2000WO2000053759A1 Expression of human alpha-fetoprotein in mammalian cells
09/14/2000WO2000053758A2 Compositions and methods for the treatment of immune related diseases
09/14/2000WO2000053757A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000WO2000053756A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/14/2000WO2000053755A2 Compositions and methods for the treatment of tumor
09/14/2000WO2000053754A1 Compositions and methods for the treatment of tumor
09/14/2000WO2000053753A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000WO2000053752A2 Promotion or inhibition of angiogenesis and cardiovascularization
09/14/2000WO2000053751A1 Methods and compositions for inhibiting neoplastic cell growth
09/14/2000WO2000053750A1 Compositions and methods for the treatment of tumors
09/14/2000WO2000053749A2 Vascular adhesion molecules and modulation of their function
09/14/2000WO2000053748A2 Casb618 polynucleotides and polypeptides and their use
09/14/2000WO2000053747A1 Sialic acid-binding ig-like lectin (siglec) gene; ob-binding protein like (ob-bpl)
09/14/2000WO2000053746A2 Method of delaying or inhibiting sprouting in plants
09/14/2000WO2000053745A1 Oligonucleotides containing an antisense sequence stabilised by a secondary structure and pharmaceutical compositions containing same
09/14/2000WO2000053744A2 End selection in directed evolution
09/14/2000WO2000053743A1 Methods and reagents for identifying synthetic genetic elements
09/14/2000WO2000053742A2 Polynucleotides and proteins encoded thereby
09/14/2000WO2000053741A1 Dna binding proteins that interact with npr1
09/14/2000WO2000053740A1 Method for screening biomolecule activity regulator
09/14/2000WO2000053739A1 Fibers having nucleic acid immobilized thereon, alignment of fibers having nucleic acid immobilized thereon and slice thereof
09/14/2000WO2000053738A2 Methods and compositions for regulating memory consolidation
09/14/2000WO2000053737A2 Mitomycin biosynthetic gene cluster
09/14/2000WO2000053736A1 Carriers having biological substance
09/14/2000WO2000053735A2 Methods for identifying modulators of synaptic plasticity and cell motility
09/14/2000WO2000053733A2 Hermansky pudlak syndrome protein-interacting proteins and methods of use thereof
09/14/2000WO2000053732A2 Class ii dna methyltransferases of zea mays
09/14/2000WO2000053730A2 Medical preparations for the treatment of alpha-galactosidase a deficiency
09/14/2000WO2000053729A2 Viral particles which are released after the infection with the human cytomegalovirus and the use of said particles as a vaccine
09/14/2000WO2000053726A1 Process for producing l-lysine
09/14/2000WO2000053724A2 Compositions and methods for the modification of gene transcription
09/14/2000WO2000053723A2 Scarecrow gene, promoter and uses thereof
09/14/2000WO2000053722A2 Delivery of nucleic acids and proteins to cells
09/14/2000WO2000053636A2 Dsp-1 dual-specificity map kinase phosphatase
09/14/2000WO2000053635A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions
09/14/2000WO2000053634A1 Single-stranded fv inducing apoptosis
09/14/2000WO2000053633A2 Antibody and chemokine constructs that are directed to ccr5, and their use for treating autoimmune diseases
09/14/2000WO2000053631A1 Mammalian cytokines; related reagents and methods
09/14/2000WO2000053628A2 Genes encoding human potassium channel proteins
09/14/2000WO2000053617A1 Methods and compositions for economically synthesizing and assembling long dna sequences
09/14/2000WO2000053616A2 Nucleotides and polynucleotides immobilised on a solid support via a disulphide linkage
09/14/2000WO2000053232A1 Matriptase, a serine protease and its applications
09/14/2000WO2000053229A2 Protein conjugates on the basis of lumazine synthase, methods for producing them and the use thereof
09/14/2000WO2000053223A1 Apoptosis inducing molecule ii and methods of use
09/14/2000WO2000053218A1 Neurodegenerative disorder related gene
09/14/2000WO2000053216A2 Use of casb616 polypeptides and polynucleotides for cancer treatment
09/14/2000WO2000053213A2 Cyanovirin conjugates, matrix-anchored cyanovirin and anti-cyanovirin antibody, and related compositions and methods of use
09/14/2000WO2000053163A1 Bacterial ghosts as carrier and targeting vehicles
09/14/2000WO2000053161A2 Microparticles for delivery of nucleic acid
09/14/2000WO2000053019A1 Dna vaccination for treatment of autoimmune disease
09/14/2000WO2000053005A1 HETEROGENOUS AND HOMOGENEOUS MOUSE VARIANTS LACKING sno GENE
09/14/2000WO2000053000A1 Plants and feed baits for controlling damage from feeding insects
09/14/2000WO2000044914B1 Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
09/14/2000WO2000038737A3 GENE THERAPY FOR PULMONARY EDEMA USING ADENOVIRUS VECTORS ENCODING Na,K-ATPase
09/14/2000WO2000037685A3 Method of identifying a psychotropic agent using differential gene expression
09/14/2000WO2000037675A3 Reporter gene assay for compounds which mimic or inhibit the physiological effect of the ob-protein
09/14/2000WO2000037656A3 Flavonoid biosynthetic enzymes
09/14/2000WO2000037654A3 Phenol oxidizing enzymes from funghi
09/14/2000WO2000037651A3 Method of screening for agrochemicals
09/14/2000WO2000037609A3 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
09/14/2000WO2000037504A3 Human monoclonal antibodies to ctla-4
09/14/2000WO2000037488A3 Mads-box genes and uses thereof
09/14/2000WO2000037102A3 Improvement of tolerance to a xenograft
09/14/2000WO2000036911A3 Method for the regeneration of cotton
09/14/2000WO2000035430A3 Homer a new target of treating psychiatric disorders
09/14/2000WO2000035409A3 Hiv-i fusion inhibition compounds
09/14/2000WO2000034496A3 Use of trans-activation and cis-activation to modulate the persistence of expression of a transgene
09/14/2000WO2000032791A3 Plan lecithin:cholesterol acyltransferases
09/14/2000WO2000031263A3 Gtpase associated proteins
09/14/2000WO2000031132A8 Novel polypeptide
09/14/2000WO2000030587A3 NF-λB ACTIVATION INHIBITORS, AND THEIR PHARMACEUTICAL USES
09/14/2000WO2000029586A3 Maize dna ligase i orthologue and uses thereof
09/14/2000WO2000028055A3 Hypersensitive response elicitor-induced stress resistance
09/14/2000WO2000028012A3 THE USE OF β-GLUCOSIDASE TO ENHANCE DISEASE RESISTANCE AND RESISTANCE TO INSECTS IN CROP PLANTS
09/14/2000WO2000027883B1 A method of treating tumors using fas-induced apoptosis
09/14/2000WO2000026408A3 A system for cell-based screening
09/14/2000WO2000026395A3 Bovine cells expressing adenovirus essential functions for propagation of recombinant adenoviral vectors
09/14/2000WO2000025818A8 asuE/trmU
09/14/2000WO2000024913A3 Mn gene and protein
09/14/2000WO2000024893A3 Methods and compositions for the prevention and treatment of anemia
09/14/2000WO2000024770A3 Dimeric thrombopoietin peptide mimetics binding to mp1 receptor and having thrombopoietic activity
09/14/2000WO2000023603A3 Methods of treatment of type 2 diabetes
09/14/2000WO2000023599A3 Human proteins involved in endoplasmic reticulum protein degradation
09/14/2000WO2000023588B1 G-protein coupled receptors
09/14/2000WO2000022166A3 Genes for assessing cardiovascular status and compositions for use thereof
09/14/2000WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors
09/14/2000WO2000022125A9 6-protein-coupled receptor-like proteins, polynucleotides encoded by them, and methods of using same
09/14/2000WO2000020452A9 Hypersensitive response elicitor fragments which are active but do not elicit a hypersensitive response
09/14/2000WO2000018939A9 Method of plant transformation
09/14/2000WO2000013018A3 Support for a method for determining analytes and a method for producing the support
09/14/2000WO2000000624A8 Production of urokinase in plant-based expression systems
09/14/2000WO1999066875A3 Combined preparation of anti-infectiously active compounds which inhibit the 2-c-methylerythrose-4 metabolic pathway, and inhibitors of lipid metabolism
09/14/2000WO1999064624A3 Method of generating nucleic acid hybrids for mutation analysis
09/14/2000WO1999062941A9 Serpentine transmembrane antigens expressed in human cancers and uses thereof
09/14/2000DE19911684A1 Human nucleic acid sequences from endothelial cells useful for treatment of angiogenic disease, including psoriasis, arthritis and diabetic retinopathy, etc
09/14/2000DE19910044A1 Virale Partikel, die nach Infektion durch humanes Cytomegalovirus freigesetzt werden und ihre Verwendung als Impfstoff Viral particles released after infection by human cytomegalovirus and their use as a vaccine
09/14/2000CA2833396A1 Treatment of alpha-galactosidase a deficiency
09/14/2000CA2582809A1 Replica amplification of nucleic acid arrays
1 ... 3185 3186 3187 3188 3189 3190 3191 3192 3193 3194 3195 3196 3197 3198 3199 3200 3201 3202 3203 3204 3205 ... 4023